EUVIMEDEUVIMED entdecken
Crossref

Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation

Işılay Turan iD, Selami Ulaş iD, Sezin Naiboğlu iD, Pınar Gökmirza iD, Serdar Al iD, Mehmet Halil Çeliksoy iD, Çiğdem Aydoğmuş iD

Scandinavian Journal of Immunology · 2026-04 · 103 (4)

DOI: 10.1111/sji.70116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 24.04.2026. Verfasst von Işılay Turan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology and Allergy, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Homeodomain Proteins, DNA-Binding Proteins, Mutation, Severe Combined Immunodeficiency. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombination‐activating genes (RAG1 and RAG2) encode lymphoid‐specific proteins that are essential for V(D)J recombination during early T‐ and B‐lymphocyte development. Biallelic mutations in these genes result in a broad spectrum of primary immunodeficiency phenotypes, ranging from classical severe combined immunodeficiency (SCID) to combined immunodeficiency, immune dysregulation, autoimmunity, and inflammatory complications. The immunological phenotype varies widely, from T‐B‐NK+ severe combined immunodeficiency (SCID) to combined immunodeficiency (CID), or near‐normal T and B cell counts, and even antibody deficiencies despite preserved pathogen‐specific antibody responses. In this cohort, we aimed to characterize the clinical, immunological, and genetic features, as well as the disease course, of patients diagnosed with RAG1 and RAG2 deficiencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Homeodomain ProteinsDNA-Binding ProteinsMutationSevere Combined ImmunodeficiencyNuclear ProteinsHumansPhenotypeFemaleInfantMaleB-LymphocytesChild, PreschoolT-LymphocytesChild

Stichwörter der Autor:innen

RAG deficiencyRAG1/2primary immunodeficienciessevere combined immunodeficiency

Substanzen

Homeodomain ProteinsRAG2 protein, humanDNA-Binding ProteinsRAG-1 proteinNuclear Proteins

Autor:innen und Institutionen

  • Department of Pediatric Immunology and Allergy, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

ORCID-Profile: Işılay Turan, Selami Ulaş, Sezin Naiboğlu, Pınar Gökmirza, Serdar Al, Mehmet Halil Çeliksoy, Çiğdem Aydoğmuş

Zitieren

APA

Turan, I., Ulaş, S., Naiboğlu, S., Gökmirza, P., Al, S., Çeliksoy, M. H., & Aydoğmuş, Ç. (2026). Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation. Scandinavian Journal of Immunology, 103(4). https://doi.org/10.1111/sji.70116

Vancouver

Turan I, Ulaş S, Naiboğlu S, Gökmirza P, Al S, Çeliksoy MH, et al. Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation. Scandinavian Journal of Immunology. 2026;103(4). doi:10.1111/sji.70116

BibTeX
@article{Turan2026,
  author = {Turan, Işılay and Ulaş, Selami and Naiboğlu, Sezin and Gökmirza, Pınar and Al, Serdar and Çeliksoy, Mehmet Halil and Aydoğmuş, Çiğdem},
  title = {Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation},
  journal = {Scandinavian Journal of Immunology},
  year = {2026},
  volume = {103},
  number = {4},
  doi = {10.1111/sji.70116}
}
Kostenlos starten →